Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05571618
The Rechallenge of ADCs in MBC Patients
Sponsor: Fudan University
View on ClinicalTrials.gov
Summary
To investigate the efficacy and safety of ADC rechallenge
Official title: A Multicenter, Real-world Study of the Efficacy and Safety of Antibody-drug Conjugates (ADCs) Rechallenge in Patients with Prior Exposure to ADCs Metastatic Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2022-09-01
Completion Date
2025-03-01
Last Updated
2024-10-21
Healthy Volunteers
No
Conditions
Interventions
DRUG
ADC
Patients with prior exposure to ADC (either in the adjuvant setting or metastatic disease are allowed).
Locations (1)
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China